Research graph
References from Platform‐Specific Immunoassay Development and Orthogonal Characterization for Improved Host Cell Protein Control in Vero Cell‐Derived Vaccines. Local targets link to admitted publications; unresolved targets remain external evidence.
Comparison of Purification Strategies for Antibodies Used in a Broad Spectrum Host Cell Protein Immunoassay
10.1002/bit.26482 · 2018 · External reference
CRISPR‐Editing of the Vero Cell Line Improves Processability of Live Virus Vaccines by Enabling Targeted Proteolysis of Fibronectin
10.1002/bit.29028 · 2025 · External reference
Host Cell Protein Clinical Safety Risk Assessment‐An Updated Industry Review
10.1002/bit.70029 · 2025 · External reference
Preclinical Immunogenicity and Efficacy of a Candidate COVID‐19 Vaccine Based on a Vesicular Stomatitis Virus‐SARS‐CoV‐2 Chimera
10.1016/j.ebiom.2022.104203 · 2022 · External reference
Fragmentation of a Highly Purified Monoclonal Antibody Attributed to Residual CHO Cell Protease Activity
10.1002/bit.22982 · 2011 · External reference
Targeted Host Cell Protein Quantification by LC–MRM Enables Biologics Processing and Product Characterization
10.1021/acs.analchem.9b03952 · 2020 · External reference
Understanding the Spike Protein in COVID‐19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots
10.1021/acsomega.2c06937 · 2023 · External reference
Automated, Quantitative Capillary Western Blots to Analyze Host Cell Proteins in COVID‐19 Vaccine Produced in Vero Cell Line
10.3390/vaccines12121373 · 2024 · External reference
Insights in ChAdOx1 nCoV‐19 Vaccine‐Induced Immune Thrombotic Thrombocytopenia
10.1182/blood.2021013231 · 2021 · External reference
Optimization for the Production of a Dengue Live‐Attenuated Quadrivalent Vaccine in Vero Cells Grown on Microcarriers
2025 · External reference
Enzyme‐Linked Immunosorbent Assay: Types and Applications
10.1007/978-1-0716-2903-1_1 · 2023 · External reference
A Microfluidic Approach to High Throughput Quantification of Host Cell Protein Impurities for Bioprocess Development
10.4155/pbp.14.12 · 2014 · External reference
A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies
10.1021/acs.analchem.7b00304 · 2017 · External reference
High‐Risk” Host Cell Proteins (HCPs): A Multi‐Company Collaborative View
10.1002/bit.27808 · 2021 · External reference
Enrichment of Low‐Abundant Protein Targets by Immunoprecipitation Upstream of Mass Spectrometry
10.1007/978-1-4939-2550-6_12 · 2015 · External reference
Variation in the Performance of Different Batches of Two Mycobacterium avium Subspecies Paratuberculosis Antibody ELISAs Used for Pooled Milk Samples
10.3390/ani12040442 · 2022 · External reference
Regeneration of Capto Core 700 Resin Through High Throughput and Laboratory Scale Studies and Impact on Production of a SARS‐CoV‐2 Vaccine Candidate
10.1002/biot.202200191 · 2022 · External reference
Purification Processes of Live Virus Vaccine Candidates Expressed in Adherent Vero Cell Lines via Multimodal Chromatography in Flowthrough Mode
10.1002/bit.28430 · 2024 · External reference
Host Cell Protein Profiling by Targeted and Untargeted Analysis of Data Independent Acquisition Mass Spectrometry Data With Parallel Reaction Monitoring Verification
10.1021/acs.analchem.6b04892 · 2017 · External reference
Process‐ and Product‐Related Impurities in the ChAdOx1 nCov‐19 Vaccine
10.7554/elife.78513 · 2022 · External reference
Adaptation of an rVSV Ebola Vaccine Purification Process for Rapid Development of a Viral Vaccine Candidate for Sars‐Cov‐2
10.1002/biot.202300041 · 2024 · External reference
Applications of Capillary Electrophoresis for Biopharmaceutical Product Characterization
10.1002/elps.202100182 · 2022 · External reference
Sensitive Methods for Evaluation of Antibodies for Host Cell Protein Analysis and Screening of Impurities in a Vaccine Process
10.1016/j.vaccine.2014.02.032 · 2014 · External reference
Lot‐to‐Lot Variance in Immunoassays‐Causes, Consequences, and Solutions
10.3390/diagnostics13111835 · 2023 · External reference
Comparison of COVID‐19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada
10.1001/jamanetworkopen.2021.14531 · 2021 · External reference
Protein Purification and Analysis: Next Generation Western Blotting Techniques
10.1080/14789450.2017.1388167 · 2017 · External reference
Clinical Features of Vaccine‐Induced Immune Thrombocytopenia and Thrombosis
10.1056/nejmoa2109908 · 2021 · External reference
Quantitation of Host Cell Proteins in Biopharmaceuticals From Chinese Hamster Ovarian and Vero Cell Lines Using Capillary Electrophoresis Western Blots
10.1016/j.jpba.2023.115420 · 2023 · External reference
Monitoring Process‐Related Impurities in Biologics‐Host Cell Protein Analysis
10.1007/s00216-021-03648-2 · 2022 · External reference
Principles and Applications of Liquid Chromatography‐Mass Spectrometry in Clinical Biochemistry
2009 · External reference
Safety and Immunogenicity of Intramuscular, Single‐Dose V590 (rVSV‐SARS‐CoV‐2 Vaccine) in Healthy Adults: Results From a Phase 1 Randomised, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Trial
10.1016/j.ebiom.2022.104138 · 2022 · External reference
Enzyme‐Linked Immunosorbent Assay for the Quantitative/Qualitative Analysis of Plant Secondary Metabolites
10.1007/s11418-017-1144-z · 2018 · External reference
Surface Plasmon Resonance as a High Throughput Method to Evaluate Specific and Non‐Specific Binding of Nanotherapeutics
10.1016/j.jconrel.2015.09.048 · 2015 · External reference
Fibronectin and Its Role in Human Infective Diseases
10.3390/cells8121516 · 2019 · External reference
The Use of Viral Vectors in Vaccine Development
10.1038/s41541-022-00503-y · 2022 · External reference
Host Cell Protein Analysis in Therapeutic Protein Bioprocessing ‐ Methods and Applications
10.1002/biot.201200018 · 2013 · External reference
Methods for Addressing Host Cell Protein Impurities in Biopharmaceutical Product Development
10.1002/biot.202200115 · 2023 · External reference
Experience With Host Cell Protein Impurities in Biopharmaceuticals
10.1002/btpr.2640 · 2018 · External reference
Using Surface Plasmon Resonance to Quantitatively Assess Lipid‐Protein Interactions
10.1007/978-1-4939-3170-5_12 · 2016 · External reference
Host Cell Proteins in Biotechnology‐Derived Products: A Risk Assessment Framework
10.1002/bit.25647 · 2015 · External reference
Affinity Chromatography for Vaccines Manufacturing: Finally Ready for Prime Time?
10.1016/j.vaccine.2018.02.090 · 2019 · External reference
Host Cell Protein Testing by ELISAs and the Use of Orthogonal Methods
10.1002/bit.25327 · 2014 · External reference
